Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 87 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 7517987

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Apr 14, 2009 · Expires Apr 9, 2029

    granted

  2. US 7514448

    Azaindoles useful as inhibitors of rock and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Apr 7, 2009 · Expires Apr 2, 2029

    granted

  3. US 7511038

    Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors

    Laboratories Almirall, S.A. · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted

  4. US 7510710

    Compositions of UCP inhibitors, Fas antibody, a fatty acid metabolism inhibitor and/or a glucose metabolism inhibitor

    The Regents of the University of Colorado · Granted Mar 31, 2009 · Expires Mar 26, 2029

    granted

  5. US 7507826

    Azaindoles useful as inhibitors of JAK and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Mar 24, 2009 · Expires Mar 19, 2029

    granted

  6. US 7504430

    Maleiimide anti-tumor phosphatase inhibitors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 17, 2009 · Expires Mar 12, 2029

    granted

  7. US 7501415

    Selective inhibitors of ERK protein kinase and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Mar 10, 2009 · Expires Mar 5, 2029

    granted

  8. US 7495014

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Feb 24, 2009 · Expires Feb 19, 2029

    granted

  9. US 7494988

    Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

    Vertex Pharmaceuticals Incorporated · Granted Feb 24, 2009 · Expires Feb 19, 2029

    granted

  10. US 7491730

    Compositions useful as inhibitors of GSK-3

    Vertex Pharmaceuticals Incorporated · Granted Feb 17, 2009 · Expires Feb 12, 2029

    granted

  11. US 7488727

    Thiazole compounds useful as inhibitors of protein kinase

    Vertex Pharmaceuticals Incorporated · Granted Feb 10, 2009 · Expires Feb 5, 2029

    granted

  12. US 7485664

    Inhibitors of TACE

    Vertex Pharmaceuticals Incorporated · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted

  13. US 7482002

    Method of administering and using VEGF inhibitors for the treatment of prostate cancer

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 27, 2009 · Expires Jan 22, 2029

    granted

  14. US 7479272

    Method of administering and using VEGF inhibitors for the treatment of breast cancer

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 20, 2009 · Expires Jan 15, 2029

    granted

  15. US 7479275

    Method of administering and using VEGF inhibitors for the treatment of colorectal cancer

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 20, 2009 · Expires Jan 15, 2029

    granted

  16. US 7479273

    Method of administering and using VEGF inhibitors for the treatment of renal cell cancer

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 20, 2009 · Expires Jan 15, 2029

    granted

  17. US 7479274

    Method of administering and using VEGF inhibitors for the treatment of pancreatic carcinoma

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 20, 2009 · Expires Jan 15, 2029

    granted

  18. US 7470700

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Dec 30, 2008 · Expires Dec 25, 2028

    granted

  19. US 7470776

    Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof

    The Board of Regents of the University of Oklahoma · Granted Dec 30, 2008 · Expires Dec 25, 2028

    granted

  20. US 7470790

    Heteroaromatic selective inhibitors of neuronal nitric oxide synthase

    Northwestern University · Granted Dec 30, 2008 · Expires Dec 25, 2028

    granted

  21. US 7468379

    Inhibition of osteolytic lesions by SRC kinase inhibitors

    The Board of Regents of the University of Texas System · Granted Dec 23, 2008 · Expires Dec 18, 2028

    granted

  22. US 7462612

    Pyridine inhibitors of ERK2 and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Dec 9, 2008 · Expires Dec 4, 2028

    granted

  23. US 7459453

    Pyridazin-3(2H)-one derivatives as PDE4 inhibitors

    Laboratories Almirall, S.A. · Granted Dec 2, 2008 · Expires Nov 27, 2028

    granted

  24. US 7456190

    Compositions useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Nov 25, 2008 · Expires Nov 20, 2028

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.